Results 261 to 270 of about 77,953 (304)

High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing

European Journal of Clinical Microbiology & Infectious Diseases, 2020
Longitudinal studies regarding the reproducibility of Interferon-gamma release assay (IGRA) T-SPOT.TB for the diagnosis of Mycobacterium tuberculosis (M. tb) infection in serial testing are limited. We retrospectively analysed results of serially tested subjects in a medical laboratory in Germany over a time period of 14 years.
Thomas Meier, Martin Enders
openaire   +2 more sources

Absence of interferon-gamma release assay conversion following tuberculin skin testing

The International Journal of Tuberculosis and Lung Disease, 2011
The tuberculin skin test (TST) has been the established screening method for tuberculosis (TB) for over a century. Interferon-gamma release assays (IGRAs) using Mycobacterium tuberculosis-specific antigens are increasingly used as diagnostic tests for TB.
Ritz, N., Yau, C., Connell, T.G., Tebruegge, M., Leslie, D., Curtis, N.   +5 more
openaire   +3 more sources

Interferon‐gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis

International Journal of Rheumatic Diseases, 2013
AbstractObjectiveThe aim of this study was to analyze the results of interferon‐gamma release assays (IGRAs) and tuberculin skin tests (TST) performed to detect latent tuberculosis infection (LTBI) in patients with rheumatoid arthritis (RA).MethodsInterferon‐γ release assays and TST test results were summarized and systematically reviewed.ResultsFour ...
Gwan Gyu, Song, Sang-Cheol, Bae, Young Ho, Lee   +2 more
openaire   +2 more sources

Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection

Acta Clinica Belgica, 2014
Accurate detection of latent tuberculosis infection (LTBI) is becoming increasingly important due to the increasing use of immunosuppressive medications and the human immunodeficiency epidemic, which have increased the risk for reactivation to active tuberculosis (TB) infection.
E, De Keyser, F, De Keyser, F, De Baets
openaire   +2 more sources

Acceptability of interferon-gamma release assays among healthcare workers who receive routine employee tuberculosis testing

International Journal of Occupational and Environmental Health, 2010
Healthcare workers (HCWs) undergo annual testing for latent tuberculosis infection (LTBI).Compare acceptability of tuberculin skin test (TST) and interferon-gamma release assay (IGRA) among HCWs.HCWs at four medical centers in the US were administered an acceptability questionnaire including a brief objective description of both tests and eliciting ...
Yael, Hirsch-Moverman, Kirsten, Wall, Paul, Weinfurter, Elizabeth, Munk, Joyce Ann, Moran, Allison, Maiuris, Amera, Khan, Nichlas, DeLuca   +7 more
openaire   +2 more sources

Tuberculin skin test versus interferon‐gamma release assay in refugee children: A retrospective cohort study

Journal of Paediatrics and Child Health, 2018
AimThe aim of this study was to assist clinicians evaluating refugee children for latent tuberculosis infection (LTBI) by comparing paired tuberculin skin test (TST) and Quantiferon Gold In‐Tube (QGIT) test results with clinical management decisions and follow‐up data in a large cohort of newly arrived refugee children.MethodsThis was a retrospective ...
Chris, Elliot, Ben, Marais, Phoebe, Williams, Paul, Joshua, Sherri, Towle, Graham, Hart, Karen, Zwi   +6 more
openaire   +2 more sources

An interferon-gamma release assay test performs well in routine screening for tuberculosis.

Danish medical journal, 2014
A positive interferon-gamma release assay (IGRA) is regarded as proof of latent Mycobacterium tuberculosis infection. We conducted an evaluation of the IGRA test "T-SPOT.TB" to test its performance during clinical routine use by analysing the positivity rate and odds, effect of season and sensitivity.Data from T-SPOT.TB testing together with age and ...
Vestergaard Danielsen, Allan, Fløe, Andreas, Lillebæk, Troels, Hoffmann, Hans Jürgen, Hilberg, Ole   +4 more
openaire   +2 more sources

In vitro interferon-gamma release test in patients with drug-induced pemphigus.

The Israel Medical Association journal : IMAJ, 2008
Drug-specific CD8+ TH1 lymphocytes have been found in the peripheral blood and involved skin of patients with drug-induced bullous exanthems.To determine whether the interferon-gamma release test can identify culprit drugs in pemphigus patients.Clinical and laboratory workup for pemphigus was performed in 14 pemphigus vulgaris patients who had been ...
Ilan, Goldberg, Idit, Shirazi, Sarah, Brenner   +2 more
openaire   +1 more source

Comparison of interferon-gamma release assay and tuberculin test for screening in healthcare workers.

Revista portuguesa de pneumologia, 2010
Healthcare workers (HCWs) have an increased risk of tuberculosis (TB). Screening for latent tuberculosis infection and active TB is therefore essential in infection control programs. Tuberculin skin test (TST) and Interferon -gamma Release Assay (IGRA) were used simultaneously in 1686 HCWs between May 2007 and April 2009.
José Torres, Costa, Rui, Silva, Raul, Sá, Maria João, Cardoso, Carla, Ribeiro, Albert, Nienhaus   +5 more
openaire   +2 more sources

Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins.

International journal of dermatology, 2010
An increasing number of cutaneous adverse effects are being reported as use of statins becomes more widespread. A study was undertaken to establish the relationship between statin and a cutaneous reaction by the in vitro interferon-gamma (INF-gamma) release test.The lymphocytes of 20 patients with suspected drug-induced skin reaction were incubated ...
Ilan, Goldberg, Gila, Isman, Idit, Shirazi, Sarah, Brenner   +3 more
openaire   +1 more source